![Global Drug R&D Express (May 2024)](https://synapse-tour.cdn.patsnap.com/synapse/open_resource/report/prod/data/report/20240717/0857/34a2/0ac4/eecb/085734a20ac4eecb_300w.webp)
Global Drug R&D Express (May 2024)
This report compiles and summarizes the basic information of all the first-to-market and special review drugs globally for the month of May totaling 95 drugs. Among them, 1 first-to-market drugs and 2 drugs under special review were selected for detailed analysis. The report provides an in-depth interpretation of these drugs, covering various aspects such as basic information, development status, technological barriers, mechanism of action, clinical trials, and competitive landscape.